[Is the DDAVP-test helpful to diagnose children?]

E Weissenbacher1, B Acham-Roschitz, B Leschnik

  • 1Medical University of Graz, Auenbruggerplatz 30, A-8036 Graz, Austria. wolfgang.muntean@meduni-graz.at

Hamostaseologie
|November 3, 2010
PubMed

Insights

The DDAVP test is not a reliable diagnostic tool for identifying mild von Willebrand disease (VWD) in children with borderline VWF parameters. A positive response to DDAVP does not significantly correlate with bleeding history in diagnosing VWD.

Area of Science:

  • Hematology
  • Pediatric Medicine
  • Diagnostic Testing

Context:

  • Diagnosing von Willebrand disease (VWD) in pediatric patients with borderline VWF parameters presents challenges.
  • The 'grey area' of VWD makes it difficult to distinguish mild disease from low-normal VWF levels, especially given difficulties in assessing children's bleeding history.

Purpose:

  • To evaluate the efficacy of the 1-deamino-8-D-arginine vasopressin (DDAVP) test as a diagnostic tool for VWD in pediatric patients with borderline VWF parameters.
  • To determine if DDAVP response correlates with bleeding history in this patient group.

Summary:

  • A retrospective analysis of 52 pediatric patients with borderline VWD evaluated the DDAVP test's diagnostic utility.
  • While all patients showed a good response to DDAVP, the increase in VWF:Ag, VWF:RiCof, and FVIII:C did not significantly differ between patients with positive and negative bleeding histories.
  • The study found no significant association between a positive bleeding history and a lower DDAVP response, nor between a high response and a negative history.

Impact:

  • The DDAVP test is not a suitable diagnostic tool for the 'grey area' of VWD in pediatric patients.
  • This finding highlights the need for alternative diagnostic strategies for VWD in children with borderline VWF levels.
Abstract